125 related articles for article (PubMed ID: 11105897)
1. Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate.
Tracey WD; Speck NA
Semin Cell Dev Biol; 2000 Oct; 11(5):337-42. PubMed ID: 11105897
[TBL] [Abstract][Full Text] [Related]
2. Core binding factor and its role in normal hematopoietic development.
Speck NA
Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154
[TBL] [Abstract][Full Text] [Related]
3. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
4. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
Ganly P; Walker LC; Morris CM
Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.
Waltzer L; Ferjoux G; Bataillé L; Haenlin M
EMBO J; 2003 Dec; 22(24):6516-25. PubMed ID: 14657024
[TBL] [Abstract][Full Text] [Related]
6. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
7. Core-binding factors in hematopoiesis and immune function.
de Bruijn MF; Speck NA
Oncogene; 2004 May; 23(24):4238-48. PubMed ID: 15156179
[TBL] [Abstract][Full Text] [Related]
8. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.
Wang Q; Stacy T; Miller JD; Lewis AF; Gu TL; Huang X; Bushweller JH; Bories JC; Alt FW; Ryan G; Liu PP; Wynshaw-Boris A; Binder M; Marín-Padilla M; Sharpe AH; Speck NA
Cell; 1996 Nov; 87(4):697-708. PubMed ID: 8929538
[TBL] [Abstract][Full Text] [Related]
9. Function of CBFbeta/Bro proteins.
Adya N; Castilla LH; Liu PP
Semin Cell Dev Biol; 2000 Oct; 11(5):361-8. PubMed ID: 11105900
[TBL] [Abstract][Full Text] [Related]
10. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
[TBL] [Abstract][Full Text] [Related]
11. RUNX1/AML1: a central player in hematopoiesis.
Okuda T; Nishimura M; Nakao M; Fujita Y
Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959
[TBL] [Abstract][Full Text] [Related]
12. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.
Lian JB; Balint E; Javed A; Drissi H; Vitti R; Quinlan EJ; Zhang L; Van Wijnen AJ; Stein JL; Speck N; Stein GS
J Cell Physiol; 2003 Aug; 196(2):301-11. PubMed ID: 12811823
[TBL] [Abstract][Full Text] [Related]
13. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
14. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
Kumano K; Kurokawa M
J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
[TBL] [Abstract][Full Text] [Related]
15. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
16. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
Kurokawa M; Hirai H
Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
[TBL] [Abstract][Full Text] [Related]
17. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.
Okada H; Watanabe T; Niki M; Takano H; Chiba N; Yanai N; Tani K; Hibino H; Asano S; Mucenski ML; Ito Y; Noda T; Satake M
Oncogene; 1998 Nov; 17(18):2287-93. PubMed ID: 9811459
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells.
Lacaud G; Kouskoff V; Trumble A; Schwantz S; Keller G
Blood; 2004 Feb; 103(3):886-9. PubMed ID: 14525762
[TBL] [Abstract][Full Text] [Related]
19. [Flies, fishes and frogs turn the tide of hematopoietic research].
Ohneda K; Yamamoto M
Tanpakushitsu Kakusan Koso; 2005 May; 50(6 Suppl):633-7. PubMed ID: 15926492
[No Abstract] [Full Text] [Related]
20. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
